Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05559359 |
|---|---|
| Brief Title: | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-1) |
| First Submitted : | September 26, 2022 |
| First Submitted that Met QC Criteria : | September 26, 2022 |
| First Posted : | September 29, 2022 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 17, 2024 |